Balaji Amines Limited Stock

Equities

BALAMINES

INE050E01027

Specialty Chemicals

Market Closed - Bombay S.E. 06:00:50 2024-05-24 am EDT 5-day change 1st Jan Change
2,191 INR -1.06% Intraday chart for Balaji Amines Limited -0.87% -17.90%
Sales 2024 16.42B 198M Sales 2025 * 20.44B 246M Capitalization 70.99B 855M
Net income 2024 2.05B 24.67M Net income 2025 * 3.09B 37.26M EV / Sales 2024 4.03 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 3.47 x
P/E ratio 2024
32.3 x
P/E ratio 2025 *
23 x
Employees 1,111
Yield 2024 *
-
Yield 2025 *
-
Free-Float 31.04%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.06%
1 week-0.87%
Current month-0.01%
1 month-2.46%
3 months-1.94%
6 months+8.46%
Current year-17.90%
More quotes
1 week
2 182.05
Extreme 2182.05
2 293.70
1 month
2 070.05
Extreme 2070.05
2 422.45
Current year
2 010.00
Extreme 2010
2 716.50
1 year
2 002.00
Extreme 2002
2 736.35
3 years
1 872.90
Extreme 1872.9
5 220.00
5 years
204.10
Extreme 204.1
5 220.00
10 years
45.95
Extreme 45.95
5 220.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 89-01-14
Chairman 73 88-10-26
Director of Finance/CFO 49 13-05-10
Members of the board TitleAgeSince
Director/Board Member 69 88-10-26
Chief Executive Officer 62 89-01-14
Director/Board Member 58 23-05-19
More insiders
Date Price Change Volume
24-05-24 2,191 -1.06% 7,643
24-05-23 2,214 -1.16% 6,404
24-05-22 2,240 -0.97% 1,524
24-05-21 2,262 -0.80% 8,928
24-05-18 2,280 +3.19% 2,499

Delayed Quote Bombay S.E., May 24, 2024 at 06:00 am EDT

More quotes
Balaji Amines Limited is an India-based company, which is engaged in the business of manufacturing of specialty chemicals, aliphatic amines and derivatives. The Company’s segments include Amines & Specialty Chemicals and Hotel Division. It also owns a five-star Hotel in Solapur, Maharashtra. Its products include amines, derivatives, specialty chemicals and pharma excipients. Its amine products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA), TRIMETHYLAMINE and others. Its specialty chemical products include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE (2-P), N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and others. Its derivatives products include Di-Methyl Acetamide (DMAC); Di-Methyl Amine Hydrochloride (DMA HCL); Tri-Methyl Amine Hydrochloride (TMA HCL); Di-Ethyl Amine Hydrochloride (DEA HCL), and others. Its pharma excipients products include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,191 INR
Average target price
2,648 INR
Spread / Average Target
+20.87%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BALAMINES Stock